EVLO logo

Evelo Biosciences, Inc. (EVLO)

Profile

Full Name

Evelo Biosciences, Inc.

Ticker

NASDAQ: EVLO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 8, 2018

Indexes

Not included

Website

https://www.evelobio.com

Employees

66

Key Details

Price

$0.00(0.00%)

Market Cap

$9465.50(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$26.28(43.10% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.00
    EVLO price is $0.00

    30-Day Relative Volume

    0.00
    EVLO 30-day relative volume is 0.00

    Price Performance

    Price Most Recent Change

    0%
    EVLO price has remained unchanged on Oct 28, 2025

    Price YTD Change

    0%
    EVLO price has remained unchanged since January 1st

    Price 1-Year Change

    +150%
    EVLO price is up +150% year-on-year

    Price 3-Year Change

    -100%
    EVLO price is down -100% over the past 3 years

    Price Range

    Price All-Time High

    $398.57
    EVLO price is currently -100.00% below its historical high of $398.57

    Price 3-Year Low

    $0.00
    EVLO price is currently +400.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $9465.50
    EVLO market cap is $9465.50

    Market Cap 3-Year Change

    -100%
    EVLO market cap is down -100% over the past 3 years

    Market Cap All-Time High

    $956.58M
    EVLO market cap is currently -100.00% below its historical high of $956.58 million

    Market Cap Sector Percentile

    1.35%
    EVLO market cap is higher than 1.35% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    0%
    EVLO shares outstanding has remained unchanged year-on-year

    Shares Outstanding 3-Year Change

    +249.04%
    EVLO shares outstanding is up +249.04% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.98
    EVLO beta is 0.98

    200-day SMA

    $0.00
    EVLO price is currently -16.67% below its 200-day simple moving average

    50-day SMA

    $0.00
    EVLO price is currently equal to its 50-day simple moving average

    14-Day RSI

    50.00
    EVLO 14-day relative strength index is 50.00

    Volume

    0.00
    EVLO 30-day relative volume is 0.00

    ATR

    $0.00
    EVLO average true range is $0.00

    10-day Historical Volatility

    752.99%
    EVLO 10-day historical volatility is 752.99%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    EVLO annual revenue is $0.00

    Revenue Analysts Estimate

    -
    EVLO annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    0%
    EVLO annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.8%
    EVLO annual revenue is higher than 28.8% of companies in Healthcare sector

    EPS

    EPS

    -$26.28
    EVLO annual earnings per share is -$26.28

    EPS Analysts Estimate

    -
    EVLO annual earnings per share consensus analysts' forecast is unknown

    EPS 1-Year Change

    +43.1%
    EVLO annual earnings per share is up +43.1% year-on-year

    EPS Sector Percentile

    7.11%
    EVLO annual earnings per share is higher than 7.11% of companies in Healthcare sector

    Profit

    Gross Profit

    -$4.96M
    EVLO annual gross profit is -$4.96 million

    Gross Margin

    -
    EVLO annual gross profit margin value is unknown

    Operating Profit

    -$108.47M
    EVLO annual operating income is -$108.47 million

    Operating Margin

    -
    EVLO annual operating profit margin value is unknown

    Net Income

    -$114.53M
    EVLO annual net profit is -$114.53 million

    Net Margin

    -
    EVLO annual net profit margin value is unknown

    Expenses

    Total Expenses

    $108.47M
    EVLO annual total expenses is $108.47 million

    Operating Expenses

    $108.47M
    EVLO annual total operating expenses is $108.47 million

    Cost Of Goods Sold

    $4.96M
    EVLO annual cost of goods sold is $4.96 million

    Selling, General & Administrative Expenses

    $29.91M
    EVLO annual SG&A is $29.91 million

    Depreciation & Amortization

    $2.06M
    EVLO annual D&A is $2.06 million

    Interest Expense

    $0.00
    EVLO annual interest expense is $0.00

    Income Tax

    $930.00K
    EVLO annual income tax is $930.00 thousand

    EBIT & EBITDA

    EBIT

    -$108.92M
    EVLO annual earnings before interest & taxes is -$108.92 million

    EBITDA

    -$106.86M
    EVLO annual EBITDA is -$106.86 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $64.44M
    EVLO annual total assets is $64.44 million

    Non Current Assets

    $12.87M
    EVLO annual long term assets is $12.87 million

    Current Assets

    $51.57M
    EVLO annual total current assets is $51.57 million

    Cash and Cash Equivalents

    $47.94M
    EVLO annual cash & cash equivalents is $47.94 million

    Accounts Receivable

    -
    EVLO annual accounts receivable value is unknown

    Inventory

    $0.00
    EVLO annual inventory is $0.00

    Liabilities

    Total Liabilities

    $69.43M
    EVLO annual total liabilities is $69.43 million

    Long Term Liabilities

    $57.04M
    EVLO annual total long term liabilities is $57.04 million

    Current Liabilities

    $12.39M
    EVLO annual current liabilities is $12.39 million

    Accounts Payable

    $1.76M
    EVLO annual accounts payable is $1.76 million

    Debt

    Total Debt

    $51.14M
    EVLO annual total debt is $51.14 million

    Total Debt 1-Year Change

    -9.16%
    EVLO annual total debt is down -9.16% year-on-year

    Long Term Debt

    $48.88M
    EVLO annual long term debt is $48.88 million

    Short Term Debt

    $2.26M
    EVLO annual short term debt is $2.26 million

    Equity & Capital

    Shareholders Equity

    -$4.99M
    EVLO annual stockholders equity is -$4.99 million

    Book Value

    -$4.99M
    EVLO annual book value is -$4.99 million

    Retained Earnings

    -$529.22M
    EVLO annual retained earnings is -$529.22 million

    Working Capital

    $39.18M
    EVLO annual working capital is $39.18 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$101.23M
    EVLO annual cash from operations is -$101.23 million

    Cash From Operations 1-Year Change

    -4.66%
    EVLO annual cash from operations is down -4.66% year-on-year

    Cash From Investing

    -$622.00K
    EVLO annual cash from investing is -$622.00 thousand

    Cash From Investing 1-Year Change

    +58%
    EVLO annual cash from investing is up +58% year-on-year

    Cash From Financing

    $81.66M
    EVLO annual cash from financing is $81.66 million

    Cash From Financing 1-Year Change

    -16.29%
    EVLO annual cash from financing is down -16.29% year-on-year

    CAPEX

    CAPEX

    $622.00K
    EVLO annual capital expenditures is $622.00 thousand

    CAPEX 1-Year Change

    -59.05%
    EVLO annual capital expenditures is down -59.05% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$101.86M
    EVLO annual free cash flow is -$101.86 million

    Free Cash Flow 1-Year Change

    -3.68%
    EVLO annual free cash flow is down -3.68% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    EVLO annual gross profit margin value is unknown

    Operating Margin

    -
    EVLO annual operating profit margin value is unknown

    Net Margin

    -
    EVLO annual net profit margin value is unknown

    ROA & ROE

    ROA

    -150.38%
    EVLO annual return on assets is -150.38%

    ROE

    -6232.76%
    EVLO annual return on equity is -6232.76%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    EVLO price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    EVLO price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    0.00
    EVLO price to book ratio is 0.00

    PB Ratio Sector Percentile

    18.17%
    EVLO price to book ratio is higher than 18.17% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    EVLO price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    EVLO price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $16.70M
    EVLO enterprise value is $16.70 million

    Enterprise Value Sector Percentile

    23.61%
    EVLO enterprise value is higher than 23.61% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.22
    EVLO EV/EBITDA is -0.22

    EV/EBITDA Sector Percentile

    61.65%
    EVLO EV/EBITDA is higher than 61.65% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    4.16
    EVLO annual current ratio is 4.16

    Quick Ratio

    4.16
    EVLO annual quick ratio is 4.16

    Leverage

    Debt To Equity

    -10.24
    EVLO annual debt to equity ratio is -10.24

    Interest Coverage Ratio

    -
    EVLO annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    EVLO piotroski f-score value is unknown

    Altman Z-Score

    -16.35
    EVLO altman z-score is -16.35

    Analyst ratings

    Recent major analysts updates

    Oct 18, 23 TD Cowen
    Market Perform
    Jul 26, 23 Morgan Stanley
    Equal-Weight
    Feb 15, 23 Morgan Stanley
    Equal-Weight
    Nov 16, 22 Chardan Capital
    Neutral
    Sep 9, 22 Morgan Stanley
    Equal-Weight
    Aug 24, 22 Morgan Stanley
    Equal-Weight
    Aug 15, 22 Chardan Capital
    Buy
    Nov 2, 21 JMP Securities
    Market Outperform
    Nov 1, 21 Chardan Capital
    Buy
    Jun 23, 21 JMP Securities
    Market Outperform

    Institutional Ownership

    Screeners with EVLO included

    Stocks cheaper than 1 dollar
    US stocks
    Stocks below SMA 200
    Stocks recommended to hold
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Best performing stocks last 12 months
    Biotech Companies
    • What is the ticker symbol for Evelo Biosciences, Inc.?
    • Does Evelo Biosciences, Inc. pay dividends?
    • What sector is Evelo Biosciences, Inc. in?
    • What industry is Evelo Biosciences, Inc. in?
    • What country is Evelo Biosciences, Inc. based in?
    • When did Evelo Biosciences, Inc. go public?
    • Is Evelo Biosciences, Inc. in the S&P 500?
    • Is Evelo Biosciences, Inc. in the NASDAQ 100?
    • Is Evelo Biosciences, Inc. in the Dow Jones?
    • When was Evelo Biosciences, Inc.'s last earnings report?
    • When does Evelo Biosciences, Inc. report earnings?

    What is the ticker symbol for Evelo Biosciences, Inc.?

    The ticker symbol for Evelo Biosciences, Inc. is NASDAQ:EVLO

    Does Evelo Biosciences, Inc. pay dividends?

    No, Evelo Biosciences, Inc. does not pay dividends

    What sector is Evelo Biosciences, Inc. in?

    Evelo Biosciences, Inc. is in the Healthcare sector

    What industry is Evelo Biosciences, Inc. in?

    Evelo Biosciences, Inc. is in the Biotechnology industry

    What country is Evelo Biosciences, Inc. based in?

    Evelo Biosciences, Inc. is headquartered in United States

    When did Evelo Biosciences, Inc. go public?

    Evelo Biosciences, Inc.'s initial public offering (IPO) was on May 8, 2018

    Is Evelo Biosciences, Inc. in the S&P 500?

    No, Evelo Biosciences, Inc. is not included in the S&P 500 index

    Is Evelo Biosciences, Inc. in the NASDAQ 100?

    No, Evelo Biosciences, Inc. is not included in the NASDAQ 100 index

    Is Evelo Biosciences, Inc. in the Dow Jones?

    No, Evelo Biosciences, Inc. is not included in the Dow Jones index

    When was Evelo Biosciences, Inc.'s last earnings report?

    Evelo Biosciences, Inc.'s most recent earnings report was on March 14, 2024

    When does Evelo Biosciences, Inc. report earnings?

    The date for Evelo Biosciences, Inc.'s next earnings report has not been announced yet
    On this page